Literature DB >> 22160360

Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis.

Jean C Augustinack1, Kristen E Huber, Gheorghe M Postelnicu, Sita Kakunoori, Ruopeng Wang, André J W van der Kouwe, Lawrence L Wald, Thor D Stein, Matthew P Frosch, Bruce Fischl.   

Abstract

Entorhinal cortex displays a distinctive organization in layer II and forms small elevations on its surface called entorhinal verrucae. In Alzheimer's disease, the verrucae disappear due to neurofibrillary tangle formation and neuronal death. Isosurface models were reconstructed from high-resolution ex vivo MRI volumes scanned at 7.0 T and individual verruca were measured quantitatively for height, width, volume, and surface area on control and mild Alzheimer's cases. Mean verruca height was 0.13 ± 0.04 mm for our cognitively normal (controls) sample set whereas for mild AD samples mean height was 0.11 mm ± 0.05 mm (p < 0.001) in entorhinal cortex (n = 10 cases). These quantitative methods were validated by a significant correlation of verrucae height and volume with qualitative verrucae ratings (n = 36 cases). Entorhinal surfaces were significantly different from other cortical heights such as, cingulate, frontal, occipital, parietal and temporal cortices. Colocalization of verrucae with entorhinal islands was confirmed in ex vivo MRI and, moreover, verrucae ratings were negatively correlated to Braak and Braak pathological stage. This study characterizes novel methods to measure individual entorhinal verruca size, and shows that verrucae size correlates to Alzheimer's pathology. Taken together, these results suggest that verrucae may have the potential to serve as an early and specific morphological marker for mild cognitive impairment and Alzheimer's disease.

Entities:  

Mesh:

Year:  2011        PMID: 22160360      PMCID: PMC3278990          DOI: 10.1007/s00401-011-0929-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  51 in total

Review 1.  Neurofibrillary pathology: current status and research perspectives.

Authors:  H M Wisniewski; D Soifer
Journal:  Mech Ageing Dev       Date:  1979-01       Impact factor: 5.432

2.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

3.  Detection of entorhinal layer II using 7Tesla [corrected] magnetic resonance imaging.

Authors:  Jean C Augustinack; Andre J W van der Kouwe; Megan L Blackwell; David H Salat; Christopher J Wiggins; Matthew P Frosch; Graham C Wiggins; Andreas Potthast; Lawrence L Wald; Bruce R Fischl
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

4.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

5.  Alterations in protein synthetic capability of nerve cells in Alzheimer's disease.

Authors:  D M Mann; D Neary; P O Yates; J Lincoln; J S Snowden; P Stanworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

6.  Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians.

Authors:  Margery H Silver; Kathy Newell; Christopher Brady; E Tessa Hedley-White; Thomas T Perls
Journal:  Psychosom Med       Date:  2002 May-Jun       Impact factor: 4.312

7.  Synaptic proteins in Alzheimer's disease.

Authors:  Josef Marksteiner; Walter A Kaufmann; Peter Gurka; Christian Humpel
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

8.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

9.  Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.

Authors:  M J Ball
Journal:  Acta Neuropathol       Date:  1977-02-28       Impact factor: 17.088

10.  Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease.

Authors:  Patrick R Hof; Thierry Bussière; Gabriel Gold; Enikö Kövari; Panteleimon Giannakopoulos; Constantin Bouras; Daniel P Perl; John H Morrison
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

View more
  8 in total

Review 1.  Medial temporal cortices in ex vivo magnetic resonance imaging.

Authors:  Jean C Augustinack; André J W van der Kouwe; Bruce Fischl
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

2.  Memory Part 3: The Role of the Fornix and Clinical Cases.

Authors:  F D Raslau; J C Augustinack; A P Klein; J L Ulmer; V P Mathews; L P Mark
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-04       Impact factor: 3.825

3.  Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Authors:  Linda Mah; Malcolm A Binns; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2014-10-29       Impact factor: 4.105

4.  Entorhinal Cortex Thickness across the Human Lifespan.

Authors:  Khader M Hasan; Benson Mwangi; Bo Cao; Zafer Keser; Nicholas J Tustison; Peter Kochunov; Richard E Frye; Mirjana Savatic; Jair Soares
Journal:  J Neuroimaging       Date:  2015-10-08       Impact factor: 2.486

5.  Comprehensive cellular-resolution atlas of the adult human brain.

Authors:  Song-Lin Ding; Joshua J Royall; Susan M Sunkin; Lydia Ng; Benjamin A C Facer; Phil Lesnar; Angie Guillozet-Bongaarts; Bergen McMurray; Aaron Szafer; Tim A Dolbeare; Allison Stevens; Lee Tirrell; Thomas Benner; Shiella Caldejon; Rachel A Dalley; Nick Dee; Christopher Lau; Julie Nyhus; Melissa Reding; Zackery L Riley; David Sandman; Elaine Shen; Andre van der Kouwe; Ani Varjabedian; Michelle Wright; Lilla Zöllei; Chinh Dang; James A Knowles; Christof Koch; John W Phillips; Nenad Sestan; Paul Wohnoutka; H Ronald Zielke; John G Hohmann; Allan R Jones; Amy Bernard; Michael J Hawrylycz; Patrick R Hof; Bruce Fischl; Ed S Lein
Journal:  J Comp Neurol       Date:  2016-11-01       Impact factor: 3.215

6.  Regional staging of white matter signal abnormalities in aging and Alzheimer's disease.

Authors:  Emily R Lindemer; Douglas N Greve; Bruce R Fischl; Jean C Augustinack; David H Salat
Journal:  Neuroimage Clin       Date:  2017-01-23       Impact factor: 4.881

7.  A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

Authors:  Ellis Niemantsverdriet; Annemie Ribbens; Christine Bastin; Florence Benoit; Bruno Bergmans; Jean-Christophe Bier; Roxanne Bladt; Lene Claes; Peter Paul De Deyn; Olivier Deryck; Bernard Hanseeuw; Adrian Ivanoiu; Jean-Claude Lemper; Eric Mormont; Gaëtane Picard; Eric Salmon; Kurt Segers; Anne Sieben; Dirk Smeets; Hanne Struyfs; Evert Thiery; Jos Tournoy; Eric Triau; Anne-Marie Vanbinst; Jan Versijpt; Maria Bjerke; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.

Authors:  Justin S Sanchez; J Alex Becker; Heidi I L Jacobs; Bernard J Hanseeuw; Shu Jiang; Aaron P Schultz; Michael J Properzi; Samantha R Katz; Alexa Beiser; Claudia L Satizabal; Adrienne O'Donnell; Charles DeCarli; Ron Killiany; Georges El Fakhri; Marc D Normandin; Teresa Gómez-Isla; Yakeel T Quiroz; Dorene M Rentz; Reisa A Sperling; Sudha Seshadri; Jean Augustinack; Julie C Price; Keith A Johnson
Journal:  Sci Transl Med       Date:  2021-01-20       Impact factor: 17.956

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.